Aug 13, 2026 4:05pm EDT Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 6, 2026 8:00am EDT Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
Jul 11, 2026 CNBC published an in-depth interview of CEO Dr. Adam Mendelsohn conducted by Health and Science reporter Annika Kim Constantino on July 11, 2026.